The transition from proliferation to differentiation in colorectal cancer is regulated by the calcium activated chloride channel A1

PLoS One. 2013 Apr 12;8(4):e60861. doi: 10.1371/journal.pone.0060861. Print 2013.

Abstract

Breaking the balance between proliferation and differentiation in animal cells can lead to cancer, but the mechanisms maintaining this balance remain largely undefined. The calcium activated chloride channel A1 (CLCA1) is a member of the calcium sensitive chloride conductance family of proteins and is expressed mainly in the colon, small intestine and appendix. We show that CLCA1 plays a functional role in differentiation and proliferation of Caco-2 cells and of intestinal tissue. Caco-2 cells spontaneously differentiate either in confluent culture or when treated with butyrate, a molecule present naturally in the diet. Here, we compared CLCA1 expressional levels between patients with and without colorectal cancer (CRC) and determined the functional role of CLCA1 in differentiation and proliferation of Caco-2 cells. We showed that: 1) CLCA1 and CLCA4 expression were down-regulated significantly in CRC patients; 2) CLCA1 expression was up-regulated in Caco-2 cells induced to differentiate by confluent culture or by treatment with sodium butyrate (NaBT); 3) Knockdown of CLCA1 with siRNA significantly inhibited cell differentiation and promoted cell proliferation in Caco-2 confluent cultures, and 4) In Caco-2 3D culture, suppression of CLCA1 significantly increased cell proliferation and compromised NaBT-induced inhibition of proliferation. In conclusion, CLCA1 may contribute to promoting spontaneous differentiation and reducing proliferation of Caco-2 cells and may be a target of NaBT-induced inhibition of proliferation and therefore a potential diagnostic marker for CRC prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / genetics
  • Alkaline Phosphatase / metabolism
  • Butyrates / pharmacology
  • Caco-2 Cells
  • Cell Differentiation* / drug effects
  • Cell Differentiation* / genetics
  • Cell Proliferation / drug effects
  • Chloride Channels / genetics
  • Chloride Channels / metabolism*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology*
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Enterocytes / drug effects
  • Enterocytes / metabolism
  • Enterocytes / pathology
  • GPI-Linked Proteins / genetics
  • GPI-Linked Proteins / metabolism
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Sucrase-Isomaltase Complex / genetics
  • Sucrase-Isomaltase Complex / metabolism
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Butyrates
  • CLCA1 protein, human
  • Chloride Channels
  • GPI-Linked Proteins
  • ALPI protein, human
  • Alkaline Phosphatase
  • Sucrase-Isomaltase Complex

Grants and funding

This work was funded by NHS Endowment Fund (12/50) to LC, JP and CDM, and Friends of Anchor to JP and CDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.